Note 1 - Organization and Basis of Presentation (Details Textual) |
May 03, 2019 |
Sep. 30, 2019
USD ($)
|
Dec. 31, 2018
USD ($)
|
Sep. 30, 2018
USD ($)
|
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value, Ending Balance | $ 331,000 | $ 1,887,000 | $ 1,760,000 | |
| Retained Earnings (Accumulated Deficit), Ending Balance | (46,312,000) | $ (37,279,000) | ||
| Convertible Debt [Member] | ||||
| Notes Payable, Total | 6,600,000 | |||
| Oxford Finance, LLC [Member] | ||||
| Loans Payable, Total | $ 3,000,000 | |||
| Reverse Stock Split From [Member] | Alliqua Biomedical, Inc. [Member] | ||||
| Stockholders' Equity Note, Stock Split, Conversion Ratio | 6 | |||
| Alliqua Biomedical, Inc. [Member] | ||||
| Business Acquisition, Exchange Ratio | 0.0359 |
| X | ||||||||||
- Definition The number of new shares that will be given to existing shareholders of a company that has been acquired or that has merged with another. No definition available.
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|